155 related articles for article (PubMed ID: 11316866)
1. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
[TBL] [Abstract][Full Text] [Related]
2. Preclinical results of sirolimus treatment in transplant models.
Stepkowski SM
Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
[TBL] [Abstract][Full Text] [Related]
3. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
[TBL] [Abstract][Full Text] [Related]
5. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of rapamycin on glomerular dynamics: a micropuncture study in the rat.
Sabbatini M; Sansone G; Uccello F; De Nicola L; Nappi F; Andreucci VE
Transplantation; 2000 May; 69(9):1946-90. PubMed ID: 10830236
[TBL] [Abstract][Full Text] [Related]
7. Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.
Pereira BJ; Castro I; Burdmann EA; Malheiros DM; Yu L
Braz J Med Biol Res; 2010 Aug; 43(8):737-44. PubMed ID: 20549136
[TBL] [Abstract][Full Text] [Related]
8. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
[TBL] [Abstract][Full Text] [Related]
9. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
10. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
Napoli KL; Wang ME; Stepkowski SM; Kahan BD
Ther Drug Monit; 1998 Apr; 20(2):123-33. PubMed ID: 9558125
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
12. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
[TBL] [Abstract][Full Text] [Related]
13. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers.
Zimmerman JJ; Harper D; Getsy J; Jusko WJ
J Clin Pharmacol; 2003 Oct; 43(10):1168-76. PubMed ID: 14517200
[TBL] [Abstract][Full Text] [Related]
15. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function.
Klawitter J; Bendrick-Peart J; Rudolph B; Beckey V; Klawitter J; Haschke M; Rivard C; Chan L; Leibfritz D; Christians U; Schmitz V
Chem Res Toxicol; 2009 Jan; 22(1):118-28. PubMed ID: 19099400
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic characterization of a pig model of ciclosporin A nephrotoxicity following intravenous administration.
Cibulskyte D; Pedersen M; Jakobsen P; Hansen HE; Mortensen J
Pharmacol Res; 2007 Oct; 56(4):311-7. PubMed ID: 17870611
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A-induced nephrotoxicity is ameliorated by dose reduction and conversion to sirolimus in the rat.
Sereno J; Vala H; Nunes S; Rocha-Pereira P; Carvalho E; Alves R; Teixeira F; Reis F
J Physiol Pharmacol; 2015 Apr; 66(2):285-99. PubMed ID: 25903959
[TBL] [Abstract][Full Text] [Related]
19. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
Nielsen FT; Ottosen P; Starklint H; Dieperink H
Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.
Luo L; Sun Z; Luo G
J Surg Res; 2013 Jan; 179(1):e255-63. PubMed ID: 22480837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
